Drug and Alcohol Dependence

Article	Citations
EFFECTS OF SOCIAL DEFEAT STRESS EXPOSURE ON SPATIAL MEMORY PERFORMANCE IN SOCIALLY MONOGAMOUS MALE PRAIRIE VOLES	329
EXPLORING ASSOCIATIONS BETWEEN TRADITIONAL GENDER NORMS AND PRE-IMMIGRATION SEXUAL RISK BEHAVIORS AMONG MALE & FEMALE RECENT LATINO/A IMMIGRANTS	277
SEX AND GENOTYPE DEPENDENT DRUG-INDUCED DOPAMINE RELEASE IN ADOLESCENT CHRNA6 3’-UTR RATS	154
Drug use and needle sharing among adolescents and young adults in Nigeria: A cross-sectional secondary analysis of data from a multi-site clinical trial	117
Comparing Racial and Ethnic Differences on Access to Wellness Services for People in Substance Use Treatment	116
Receiving Medications for Opioid Use Disorder in Maryland Correctional Facilities and at a Community-Based Low-Threshold Buprenorphine Program Post-Release: Patient and Staff Perspectives	77
Sex Differences in Contextual Cocaine Seeking Behavior are Driven by Noradrenergic Signaling to the Dorsal Hippocampus	76
UTILIZING INNOVATIVE APPROACHES TO ENHANCE THE FULL POTENTIAL OF SUBSTANCE USE DATA TO BENEFIT MINORITIZED POPULATIONS	67
Misuse Potential of Medicinal Ketamine in Real-World Clinical Contexts, Part 1: Patients With At-Home Prescribed Ketamine	59
Risky Polysubstance Use Among People who Use Opioids in a Community-Based Study	56
Clinical Translation of the HR/LR Model of SUD Propensity	53
Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study	53
BRIDGING THE GAP: PRACTICAL AND ETHICAL CONSIDERATIONS ON THE UTILITY OF ARTIFICIAL INTELLIGENCE IN SUBSTANCE USE DISORDERS	53
Evaluation of Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use via Ecological Momentary Assessments	52
Beyond Rest: Unraveling the Nexus of Sleep Deficiency, Environment, Control, and their Influence on Opioid Use Disorder Treatment Outcomes	50
Provider Perspectives on Child Protective Services Reporting for Perinatal Patients With Opioid Use Disorder	50
Adolescent Gender Diversity and Substance Use Exposure: A Mediating Role of Peer Victimization	50
The Association between Poly-victimization and Opioid Misuse Among Justice-Involved Adolescents	49
The Effects of Acupuncture Stimulation at Shenmen (HT7) on Brain Stimulation Reward in Rats	47
Characterizing Substance Use Disorder on Reddit Through Network Analysis and Transitions of Use Between Opioids, Cannabis, and Other Drugs	47
A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder	47
Chronic Oral Dosing of Cannabidiol (CBD) With and Without low Doses of Delta-9-Tetrahydrocannabinol (Δ-9-THC)	43
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs	42
A Comparative Study of Behavioral Effects of Novel Designer Drugs in Male Rodents	41
Factors Associated With Self-Directed Discharge Among Hospitalized Individuals With a Substance Use Disorder	40

Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic	40
Determination of Yohimbine's Reinforcing Actions in Male and Female Rats	39
Denial of Prescription Pain Medication Among People Who Use Drugs in Vancouver, Canada	39
Nalfurafine is Aversive at Analgesic Doses - Non-Clinical Evidence to Indicate It is Not an Atypical Kappa Opioid Receptor Agonist	37
Risk of COVID-19 Hospitalization and Death in Patients on Chronic Opioid Therapy and With Opioid Use Disorder	37
Comparative Effectiveness of Intranasal Naloxone and Nalmefene in a Translational Model Assessing Reversal of Cardiac Arrest Induced by Synthetic Opioid Overdose	37
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor	37
Assessment of the Publication Trends of the Harm Reduction Studies over 40 Years	36
Neighborhood disadvantage and prescription drug misuse in low-income urban mothers	35
Rising opioid-associated skin and soft tissue infections and the emerging threat of xylazine: A national analysis	35
Associations between right inferior frontal gyrus morphometry and inhibitory control in individuals with nicotine dependence	34
The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?	34
Longitudinal patterns of opioid and stimulant use by route of administration among people who inject drugs in the South Atlantic Fentanyl Test Strip Study: A latent transition analysis	34
Development and validation of the Schedule for the Assessment of Insight in Alcohol Dependence (SAI-AD): Dimensions and correlates of insight in alcohol use disorder	33
Ethnic density effect on alcohol-related hospitalizations among Chinese enclaves and ethnoburbs in California, 2007–2011	33
XYLAZINE: AN ADULTERANT DRUG OF CONCERN	32
Avoidance of Racial Trauma Exposure and Concurrent Substance Use Among Racial/Ethnic Minoritized Young Adults	32
TERPENE AND CANNABINOID PROFILE PREFERENCES AND CANNABIS USE PRACTICES IN MEDICAL CANNABIS PATIENTS WHO USE CANNABIS FOR PAIN AND ANXIETY	32
Substance-induced mental disorders and discontinuation of medication for opioid use disorder	32
A Pilot Study of 16-Week Intensive Outpatient Treatment for Gay and Bisexual Men With Methamphetamine Use Disorder in Taiwan	32
Preferences for Abstinence-Based Recovery and Public Stigma Toward Substance Use	31
More Stress Than You Know: A Qualitative Study of Client Experiences Navigating MOUD Treatment	31
How Common is Fentanyl Contamination of Methamphetamine? Attitudes, Self-Reported Exposures, and Toxicology Data From Persons who Use Methamphetamine	31
A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market	30
A Novel Hand-Held Personalized Dual Biometrically Controlled Device for At-Home Dispensation of Methadone	30
Post-Stress Late Positive Potential Prospectively Predicts Cannabis Use Disorder Severity in Cannabis Using Women	30
Perceived Stigma on the Emotional Wellbeing Among Latinx With Substance Use Disorders: The Mediated Roles of Self-Stigma and Self-Efficacy	30
Ethical and Methodological Challenges in Studying Discontinuation of Medications for Opioid Use Disorder	29
Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine	29
SYMPOSIUM: 10 YEARS GONE: REMEMBERING BILL WOOLVERTON THROUGH HIS IMPACT ON OUR CURRENT RESEARCH PROGRAMS	29
Treatment Engagement, Cigarette Smoking, and Quit Attempts one Month After a Randomized Controlled Trial of E-Cigarette Reduction Among Dual Users	29
Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge	29
Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury	28
Use of laboratory data for illicit drug use surveillance and identification of socioeconomic risk factors	28
Letter to the Editor regarding: Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? (By Mark et al., 2021)	28
The centrality of craving in network analysis of five substance use disorders	28
Editorial Board	28
Editorial Board	28
The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs	28
Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study	28
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys	27
Cannabis use and subjective response to alcohol in the human laboratory	27
Correlates of solitary alcohol and cannabis use among American Indian adolescents	27
Corrigendum to “Longitudinal latent class analysis of tobacco use and correlates among young adults over a 10-year period” [Drug Alcohol Depend. 236 (2022) 109474]	26
Pilot randomized trial of cognitive-behavioral treatment plus contingency management for quitting smoking and weight gain prevention among smokers with overweight or obesity	26
Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis	26
Types of criminal legal system exposure and polysubstance use: Prevalence and correlates among U.S. adults in the National Survey on Drug Use and Health, 2015–2019	26
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study	26
Generational shifts in attitudes and beliefs about alcohol: An age-period-cohort approach	26
Social addiction or nicotine addiction? The effect of smoking social motivation on inhibitory control under smoking social cues: Evidence from ERPs	26

Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17	25
Punishment of ethanol choice in group-housed male cynomolgus monkeys	25
Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?	25
Reduced neural functional connectivity during working memory performance in methamphetamine use disorder	25
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis	25
CULTURALLY RESPONSIVE TRAINING TO PRACTITIONERS: REDUCING MENTAL HEALTH DISPARITIES AMONG HISPANIC AND LATINOS	24
Health care provider decision-making around prenatal substance use reporting	24
Exploring the relationship between sleep disturbances and cannabis use outcomes among Hispanic/Latino young adults	24
Relationship perceptions and conflict behavior among cannabis users	24
Polysubstance use in pregnancy: Findings from a population-based cross-sectional cohort study of pregnant women with opioid use	24
VAGINAL INSTABILITY AND DYSBIOSIS IS PREVALENT AMONG HISPANIC WOMEN LIVING IN PUERTO RICO REGARDLESS OF BODY MASS INDEX	24
Trajectories of neighborhood-level overdose risk predictions for prioritization of harm reduction services: Results from the PROVIDENT study	24
Methodological considerations when assessing symptoms of nicotine dependence by cigarette and e-cigarette use behavior and brand	23
Why Do Medical Cannabis Patients use Illicit Medicinal Cannabis in the State of Utah?	23
Qualitative Exploration of Opioid Overdose Response Steps Among Women Who Use Drugs on the Rural Eastern Shore of Maryland	23
Experiential Smoking Urges and Nicotine Withdrawal Reduction Among People Under Community Corrections Supervision Enrolled in In Vivo NRT Counseling	23
CHARACTERIZING MULTISYSTEM STIGMA: EXAMINING ITS ADVERSE IMPACT ON MOTHERS' ENGAGEMENT AND RETENTION IN RESIDENTIAL SUD TREATMENT	23
Provision of Recovery Support Services in Opioid Use Disorder (OUD) Treatment Settings: A Secondary Data Analysis of the National Survey of Substance Abuse Treatment Services (N-SSATS) Data	23
Characterizing Online Questions and Answers about Cannabis Use and Pregnancy: Data Mining and Content Analysis on the Social Media Platform Quora	23
Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009–2021	23
Associations Between Interoceptive Control of Avoidance and Patterns of Morphine Self-Administration	23
Impact of the Sudden Closure of Mexico’s Only Methadone Manufacturing Plant on the Mental, Financial and Social Health of Patients With Opioid Use Disorder (OUD) in Tijuana, Mexico	23
A Qualitative Analysis of Individual, Relationship, and Community Factors Influencing Non-Initiation of Medications for Opioid Use Disorder During Incarceration	22
“I Feel like People Would Look at Me like I’m Dirty or like I’m a Thief:” a Qualitative Exploration of Internal Experiences that Influence Recovery Among Adults at Risk of Opioid-Related Overdose	22
Conducting Community-Based Research on Substance Use in Rural Canada: Ethical and Methodological Considerations for Future Research	22
Perceptions of Cannabis and its Associations With Mental Health Amongst Budtenders in Southern Ontario	22
Maryland Opioid Overdose Deaths From 2018 to 2021: Occupational Pattern and Its Sociodemographic Variations	22
In Vivo Imaging Evidence of a Neuroinflammatory Phenotype Among Patients With Opioid Use Disorder	22
Within-Subject Evaluation of Technology-Assisted Buprenorphine Treatment	22
“Icy” Flavor Components in E-cigarette Images: Influence on Liking and Intention to Use Among Youth Who are Susceptible to E-cigarette Use	22
Liver Disease Among People who Inject drugs: A Prospective Longitudinal Cohort Study Linked to Administrative Hospital Data	22
Racialized Differences in the Prevalence of Drug Use Disorder Among Transgender Veterans	22
Who Gets Treatment And Who Gets Criminalized Racialized Associations Between Cannabis Arrests And Criminal Legal System Referrals To Cannabis Treatment, 1992-2019	21
Pharmacist Involvement in Motivational Interviewing Intervention for Patients with Prescription Opioid Misuse Behaviors	21
Rates of Medication Prescription, Mental Health Disorder, and HCV Diagnoses Among Patients With Comorbid Alcohol and Opioid Use Disorder in Rural Primary Care Clinics	21
Depression Outcomes Among Women Participating in Worth Transitions	21
Characterizing Empirically-Derived Sub-Groups of Latinx PWID Living Along the U.S.-Mexico Border for HIV and HCV Prevention	21
Protecting historically marginalized groups or targeted marketing? A computational analysis of individuals engaging with public and protected cigar-branded tweets	21
Editorial Board	21
Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems	21
NIAAA Update Presented by George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism	21
THE FAMILIAR TASTE OF POISON: A QUALITATIVE STUDY OF MULTI-LEVEL MOTIVATIONS FOR STIMULANT USE IN SEXUAL MINORITY MEN LIVING IN SOUTH FLORIDA	20
SUVOREXANT, AN FDA-APPROVED DUAL OREXIN RECEPTOR ANTAGONIST, EFFECTIVELY REDUCES OXYCODONE SELF-ADMINISTRATION AND CONDITIONED REINSTATEMENT IN MALE AND FEMALE RATS	20
Substance Co-Exposure Among Women With Opioid Use During Pregnancy	20
Primary Form of Cannabis Use and Recent Negative Affect Symptoms	20
Factors Associated With Risk for Cannabis Use Disorder Among Adults Using Medical Marijuana in Florida	20
GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE	20
DEPRESSION SCREENING AMONG PERINATAL PATIENTS WITH AND WITHOUT SUBSTANCE USE DISORDERS FOLLOWING IMPLEMENTATION OF A COLLABORATIVE CARE PROGRAM	20
Syndemic Profiles and Opioid-Related Mortality Among People Initiating Chronic Episodes of Prescription Opioid Use in BC, Canada	20
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial	20
Domestic Cannabis Cultivation: Results of the Georgian (country) Sample of the Transnational Online Survey of Cannabis Growers	20
RECENT INCARCERATION, SUBSTANCE USE, OVERDOSE, AND TREATMENT AMONG RURAL PEOPLE WHO USE DRUGS	20
Perceptions of Racism’s Impact on Drug Use Among African Americans Using Opioids	20
Brandeis/Harvard Spire Center: SUD Systems Performance Improvement Research and Engagement	20
Common and Distinct Associations Between Baseline Impulsivity and Longitudinal Development of Positive and Negative Alcohol Expectancies in the Adolescent Brain Cognitive Development (ABCD) Cohort	20
Sex Differences in the Prospective Association of Intra-Individual Reaction Time Variability in Stroop and Hazardous Cannabis Use at Six Months	19
Psychosocial and Drug Use Characteristics in Persons With Opioid Use Disorder and Chronic Pain	19
Optimizing Recovery Funding: Barriers to Acquiring Funding Among Organizations in the Ecosystem of Recovery	19
Treatment Outcomes From Computerized CBT for Substance Use Disorders Among People With Criminal Justice Involvement	19
Disparities in the Hepatitis C Virus Cascade of Care Among Reproductive Age Women With Opioid Use Disorder	19
Self-Perception of Smoking Status and Co-Use of Cannabis and Narcotic Pain Medication	19
Cannabis Use Effects on Reaction Time in Daily Versus Occasional Users	19
Performance of a Brief Substance Use Symptom Checklist (SUSC) for Identifying Substance Use Disorder Among Primary Care Patients With or at Elevated Risk for Opioid Use Disorder	19
Characterization of Peer Support Services for Substance Use Disorders in 11 U.S. Emergency Departments in 2020: Findings From a Nida Clinical Trials Network Study Site Selection Process	19
Outcomes of the Community-Based Medication-First Program for Opioid Use Disorder: A Multisite Hybrid Implementation Study	19
The defining characteristic of substance use disorders	18
Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers	18
“I still partly think this is bullshit”: A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting	18
MEDIA FORUM	18
Prevalence and socio-structural determinants of tobacco exposure in young women: Data from the Healthy Trajectories Initiative (HeLTI) study in urban Soweto, South Africa	18
Group behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: A three-arm randomized controlled trial	18
Behavioral and Psychosocial Predictors of Cannabis Use Among Youth During the COVID-19 Pandemic	18
Naloxone Stigma Among People With Substance Use Disorder: Characteristics and Associations With Stigma toward Medication for Opioid Use Disorder (MOUD)	17
Pregnancy Rates Among Women Treated With Medication for Opioid Use Disorder	17
Beyond Euphoria: Transcriptomic Investigation in the rat Brain Under the Administration of Fentanyl Combined With Xylazine	17
Barriers and Facilitators to Injectable Opioid Agonist Treatment Engagement: A Qualitative Study of Patient Experiences in Vancouver, Canada	17
Oral Oxycodone Self Administration in Rats With a History of Responding under a Multiple Schedule for Ethanol and Food or Oxycodone and Food	17
APP-BASED CONTINGENCY MANAGEMENT TO REDUCE HEAVY DRINKING DAYS AMONG SMOKERS RECEIVING VARENICLINE: FINDINGS FROM A WITHIN-SUBJECT A-B-A DESIGN TRIAL	17
Modes of Cannabis Administration and Their Associations With Binge Drinking Among 12th Grade Students in the United States: A Cross-Sectional Analysis from 2018-2021	17
Methodology for Single- vs Polydrug Classification of Poisoning Deaths	17

Perceptions of the Combining HIV Services and Microenterprise for Sustainable Recovery (CHIMES) Intervention for Sober House Residents in Tanzania: A Qualitative Study	17
SUBSTANCE USE DISORDERS AND ASSOCIATED MEDICAL CONSEQUENCES: IMPLICATIONS FOR PREVENTION AND TREATMENT	17
The Association Between Sleep Health and Multiple Tobacco Product Use Among Low-Income Smokers	16
Real-World Abuse-Related Data for a Schedule Ii Serdexmethylphenidate and Dexmethylphenidate (SDX/d-MPH) Drug Product Suggests Low Rates of Abuse	16
Editorial Board	16
How has the brain disease model of addiction contributed to tobacco control?	16
Trends in overdose deaths involving gabapentinoids and Z-drugs in the United States	16
Deficits in consummatory reward relate to severity of cocaine use	16
Sex Differences in Lifetime Non-Medical Prescription Opioid and Cannabis Use Among Older Adults in the All of Us Research Program	16
Differences in Methamphetamine Use and Self-Reported Impact by Gender and Sexual Orientation in a Multisite U.s. Cohort of People with Hiv in Care	16
Editorial Board	16
A Randomized Controlled Six-Way Crossover Study to Characterize the Nicotine Pharmacokinetics of a Novel Oral Nicotine Pouch Product	16
Associations between cannabis use, opioid misuse and severe psychological distress in adolescents: A cross-sectional school-based study	16
Mental Health Care Barriers for Women Involved in the Criminal Legal System With Substance Use Disorders: A Qualitative Study	16
Pregnenolone Effects on Cocaine Use in Individuals with Cocaine Use Disorder	16
Causally Linkage of Adolescent Behavioral Anomalies to Prenatal Opioid Exposure	16
School party culture as a driver of cocaine use among Norwegian adolescents: A cross-classified multilevel analysis	16
Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies	16
Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications	15
Associations of sex-related steroid hormones and proteins with alcohol dependence: A United Kingdom Biobank study	15
Violence, policing, and systemic racism as structural barriers to substance use treatment amongst women sex workers who use drugs: Findings of a community-based cohort in Vancouver, Canada (2010–2019)	15
Prenatal alcohol exposure and offspring subsequent alcohol use: A systematic review	15
Assessing inequities in buprenorphine treatment across the care cascade	15
Impacts of impaired control and pharmacological criteria for lifetime alcohol use disorder on relationships between drinking and problems	15
Structural indices of brain aging in methamphetamine use disorder	15
An investigation of multimodal predictors of adolescent alcohol initiation	15
Differences in tobacco smoking and alcohol consumption among 57,757 women from early to late pregnancy: A state-representative study in Queensland, Australia	15
Trends in poisonings involving ketamine in the United States, 2019–2023	15
Different brain oxidative and neuroinflammation status in rats during prolonged abstinence depending on their ethanol relapse-like drinking behavior: Effects of ethanol reintroduction	15
Cross sectional multi-sample study of nonfatal overdose in adolescents and young adults in the fentanyl era	15
Tobacco use is associated with low peripheral beta-arrestin 1 levels in major depression: A preliminary report	15
Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns	15
Alcohol use in firefighters: A network model of behaviors and transdiagnostic risk	15
Mirtazapine reduces hypothetical methamphetamine demand in humans	15
Secondhand electronic cigarette aerosol in vehicles impacts indoor air quality	15
Legality of drug checking equipment in the United States: A systematic legal analysis	15
The socioeconomic, health, and family situation of adult siblings of patients with substance use diagnosis: A descriptive registry study	15
Trajectories of delay discounting and smoking from adolescence to young adulthood	14
Trends of Prenatal Substance Exposure: A 10 Year Evaluation of Umbilical Cord Test Outcomes	14
Changes in Opioid Agonist Treatment Initiation Following Voluntary and Mandatory Prescription Drug Monitoring Program Implementation: A Time Series Analysis	14
Emotion Dysregulation Fully Mediates the Relationship between Stress and Impulsivity in Inpatients With Co-Occurring Substance Use and Mental Health Disorders	14
Incentivized Collaborative Care to Disseminate Contingency Management via Buprenorphine Treatment	14
Impact of reduced nicotine content on behavioral economic measures of cigarette reinforcement in adolescents who smoke cigarettes	14
Editorial Board	14
Oud Treatment, Harm Reduction Service Engagement, and Sexually Transmitted Infection Risk Among Men and Women who Use Illicit Opioids in New York City	14
Health Justice Coordination for Increased Access to Health and Social Services for People With Drug Use Disorders in Contact With the Criminal Justice System	14
Gender Differences in Smoking Dependence Motives	14
Exploring Long-Term Trajectories of Quality of Life for People who are Treated With Methadone	14
Positive Methamphetamine Urinalysis Result During Treatment Intake is Not Associated With Worst Treatment Outcomes Amongst Opioid Users Initiating Medication-Assisted Opioid Treatment in Rural Communi	14
Drug Decriminalization in the United States: Emerging Models, Implementation Experiences and Implications for Health and Racial Equity	14
Assessment of substance exposures in nail clipping samples: A systematic review	14
Clustering of risk behaviors and classification performance in modeling adolescent risk: The example of the association between E-cigarette use and cigarette smoking	14
Prospective association between screen use modalities and substance use experimentation in early adolescents	14
Small Business Program: Implementation of a Technological Solution to Support Treatment for Opioid Use Disorder in the Primary Care Setting	14
Access to Medications for Opioid Use Disorders: A Multi-Site Comparison of Qualitative Evidence With Stakeholders	14
High Threshold Prescribing Practices Associated With Increased Termination of Care: Results From a Survey of Michigan Buprenorphine Prescribers	14
Perceptions of Overdose Response Hotlines Among a Sample of People in Treatment for Substance Use Disorder	14
Awareness of drug supply changes and uptake of fentanyl testing services among people who use drugs in Kampala, Uganda	14
Effects of very low nicotine cigarettes, e-cigarettes, and nicotine patches on daily own-cigarette abstinence in a randomized controlled switching trial	14
CAREGIVING AND COPING: ALCOHOL USE DURING THE PANDEMIC IN NEW YORK CITY	14
Untargeted Umbilical Cord Testing to Detect Novel Psychoactive Substances	13
NEUROLOGICAL AND BEHAVIORAL CHANGES 6 MONTHS AFTER GASTRIC SLEEVE METABOLIC SURGERY	13
Editorial Board	13
An economic analysis of community costs incurred to implement the communities that HEAL intervention to reduce opioid overdose deaths in four states	13
Alcohol-Focused Treatment With Mindfulness-Oriented Recovery Enhancement Shows Additional Beneficial Effects on Craving for Other Drugs	13
Significant toxicity following an increase in poisonings with designer benzodiazepines in the Netherlands between 2010 and 2020	13
Risky alcohol use among patients dispensed opioid medications: A clinical community pharmacy study	13
WORKSHOP: NEW APPROACHES TO CULTURALLY APPROPRIATE TREATMENT AND RESEARCH	13
An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients	13
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats	13
FACTORS LINKED WITH PSYCHOLOGICAL DISTRESS IN A DIVERSE SAMPLE OF SUBSTANCE-USING ADULTS IN THE SOUTHEASTERN U.S.	13
Effects of the Social Cold Pressor Task on Stress Reactivity and Alcohol Craving and Demand	13
A Survey of Chronic Pain Patients regarding Drug Use and Opinions on Brain Stimulation as Treatment	13
Editorial Board	13
Stimulant use, HIV, and immune dysregulation among sexual minority men	13
Negative affect and craving during abstinence from smoking are both linked to default mode network connectivity	13
A Passive Addiction Recruitment Strategy Among HIV Patients in Alabama: An Opportunity for Equitable Research Participation	13
Older Adults in Opioid Use Disorder Treatment: A Systematic Review of Health Outcomes	13
Adolescent alcohol initiation: Context of close friendships and the role of trust	13
Predictors of non-fatal overdose in the month following discharge From residential treatment	12
Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey	12
Alcohol Use and Racial Discrimination in Later Generations of Latine Immigrants	12
Associations of Sexual Orientation Discordance and Sexual Identity Fluidity With Alcohol and Other Drug Use Disorders in a National US Sample	12
Concordance Between Self-Reported and Objectively Assessed Substance Use Amongst Patients Receiving Methadone or Buprenorphine for Opioid Use Disorder	12
Integrating MOUD in Non-Medical Community Organizations: Better Together MOUD (BT-MOUD)	12
Examining Engagement in Contingency Management for Smoking Cessation Among Homeless-Experienced Veterans: The Role of Dual Diagnosis	12
Intergenerational transmission of tobacco smoking: The role of the child’s behavioral difficulties. Data from the Danish National Birth cohort (DNBC)	12
Effects of NMDA receptor antagonists on behavioral economic indices of cocaine self-administration	12
U.S. older adults’ heroin and psychostimulant use treatment admissions, 2012–2019: Sociodemographic and clinical characteristics	12
The Impact of ADHD and Treatment on Opioid Misuse Among Justice-Involved Adolescents in Florida	12
Positive Subjective and Analgesic Effects of Cannabis: Implications for CUD and Therapeutic Use	12
Hours high as a proxy for marijuana use quantity in intensive longitudinal designs	12
A national study on pregaming motives, frequency, consumption, and negative alcohol consequences among university students in the United States	12
FcGBP and VCAM-1 are ponderable biomarkers for differential diagnosis of alcoholic liver cirrhosis	12
30TH ANNUAL CONTINGENCY MANAGEMENT WORKING GROUP	12